Rankings
▼
Calendar
ACET FY 2024 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena
ACET
Adicet Bio, Inc.
$76M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$128M
Net Income
-$117M
EPS (Diluted)
$-21.28
Cash Flow
Operating Cash Flow
-$92M
Free Cash Flow
-$93M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$220M
Total Liabilities
$34M
Stockholders' Equity
$187M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$128M
-$152M
+16.1%
Net Income
-$117M
-$143M
+17.9%
← Q4 2023
All Quarters
Q1 2024 →